Fly News Breaks for March 12, 2015
BCR, CRY
Mar 12, 2015 | 08:41 EDT
Piper Jaffray says CryoLife (CRY) is no longer one of its top picks after a U.S. district court ruled yesterday to temporarily enjoin the company from selling C.R. Bard's PerClot in the U.S. Piper thinks CryoLife will not be distributing PerClot topical powder "for awhile" but remains positive on the company's overall turnaround. It reiterates an Overweight rating on the name with a $15 price target.
News For CRY;BCR From the Last 2 Days
There are no results for your query CRY;BCR